Tigimak 50 Mg Injection

Product Description

Tigecycline injection used to treat certain serious infections including community acquired pneumonia (a lung infection that developed in a person who was not in the hospital), skin infections, and infections of the abdomen (area between the chest and the waist) 

Reliable Antibiotic for Serious Infections

Tigimak 50 Mg Injection is designed to combat severe bacterial infections, especially those involving the abdomen, skin, and soft tissues. Its approval by health authorities and strong clinical performance make it a dependable choice for healthcare professionals relying on hospital or clinical settings. The formulation ensures targeted action against a range of pathogens.


Convenient Single-Dose Vial Packaging

Each box of Tigimak contains a single 50 mg vial, ready for reconstitution and administration. The lyophilized powder is easily dissolved in sterile water for injection, streamlining preparation in healthcare facilities. This single-dose format facilitates accurate dosing as directed by physicians, minimizing waste and ensuring precise treatment.


Strict Storage and Handling Guidelines

Tigimak 50 Mg Injection maintains efficacy for up to 24 months from the date of manufacture if stored below 25C and protected from light. Following these storage instructions ensures the medication's stability, helping medical staff deliver safe, high-quality care to patients whenever required.